Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders

OBJECTIVES: With increasing evidence for the clinical utility of pharmacogenomic (PGx) testing for depression, there is a growing need to consider issues related to the clinical implementation of this testing. The perspectives of key stakeholders (both people with lived experience [PWLE] and provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Slomp, Caitlin, Morris, Emily, Edwards, Louisa, Hoens, Alison M., Landry, Ginny, Riches, Linda, Ridgway, Lisa, Bryan, Stirling, Austin, Jehannine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331253/
https://www.ncbi.nlm.nih.gov/pubmed/36437757
http://dx.doi.org/10.1177/07067437221140383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331253/
https://www.ncbi.nlm.nih.gov/pubmed/36437757
http://dx.doi.org/10.1177/07067437221140383

Ejemplares similares